GFFFX
Price
$74.58
Change
-$9.87 (-11.69%)
Updated
Dec 18 closing price
RAFEX
Price
$42.34
Change
-$1.53 (-3.49%)
Updated
Dec 18 closing price
Ad is loading...

GFFFX vs RAFEX

Header iconGFFFX vs RAFEX Comparison
Open Charts GFFFX vs RAFEXBanner chart's image
American Funds Growth Fund of Amer F2
Price$74.58
Change-$9.87 (-11.69%)
VolumeN/A
CapitalizationN/A
American Funds AMCAP R4
Price$42.34
Change-$1.53 (-3.49%)
VolumeN/A
CapitalizationN/A
GFFFX vs RAFEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFFFX vs. RAFEX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFFFX is a Buy and RAFEX is a Hold.

FUNDAMENTALS
Fundamentals
GFFFX has more cash in the bank: 313B vs. RAFEX (88B). GFFFX pays higher dividends than RAFEX: GFFFX (0.67) vs RAFEX (0.48). GFFFX was incepted earlier than RAFEX: GFFFX (16 years) vs RAFEX (23 years). GFFFX (31.00) and RAFEX (31.00) have comparable annual turnover. GFFFX (250) and RAFEX (250) have matching initial minimum investment requirements. GFFFX annual gain was more profitable for investors over the last year : 35.60 vs. RAFEX (18.16). GFFFX return over 5 years is better than : 56.58 vs. RAFEX (34.08).
GFFFXRAFEXGFFFX / RAFEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years23 years-
Gain YTD34.21816.874203%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets313B88B356%
Annual Yield % from dividends0.670.48140%
Returns for 1 year35.6018.16196%
Returns for 3 years19.102.02947%
Returns for 5 years56.5834.08166%
Returns for 10 years99.1058.69169%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDS488.811.22
+0.25%
Factset Research Systems
XENE41.28-0.03
-0.07%
Xenon Pharmaceuticals
JACK42.85-0.36
-0.83%
Jack In The Box
SDOT3.91-0.04
-1.01%
Sadot Group Inc
OBIO4.94-0.15
-2.95%
Orchestra BioMed Holdings